전립선암 진단의 MRI: 이점이 있습니까?

마지막 업데이트: 8월 15, 2026

• 워드프레스
• LinkedIn
• 메일

Today we are going to talk about MRI of the prostate. As I have often explained when discussing prostate cancer, this disease is frequently limited in aggressiveness. The story usually begins with a rising Prostate-Specific Antigen (PSA) blood test from a routine health check-up, which brings the patient to a urology clinic to weigh the pros and cons of a tissue biopsy and, ultimately, to reach a diagnosis. The important question is this: does every man with a suspicious PSA really need a biopsy? The answer is very often no — and here is the evidence behind that.

Autopsy studies of men who died of unrelated causes have long shown that a substantial proportion of older men are walking around with prostate cancer that never troubled them in life — and that a large share of those cancers are low-grade disease that would never have required treatment. In other words, finding a cancer is not the same as finding a cancer worth treating.

This matters because a needle biopsy of the prostate is not a trivial procedure. It can cause blood in the urine, blood in the stool, blood in the semen, and — uncommonly but importantly — a serious bloodstream infection. In the PROMIS study, close to 6% of participants reported a serious adverse event, including eight cases of sepsis.

When a biopsy is genuinely necessary, it should absolutely be done. The real challenge is knowing how to avoid the unnecessary ones. This is where MRI of the prostate has become an essential tool for urologists. Here are its main advantages and limitations.

Advantages of prostate MRI

• It is a non-invasive imaging test that provides a great deal of detail about the anatomy of the prostate gland.
• It is far more sensitive than a blind biopsy. In the PROMIS study, multiparametric MRI detected 93% of clinically significant cancers, compared with just 48% for standard transrectal ultrasound-guided biopsy.
• A negative scan is reassuring. PROMIS reported a negative predictive value of 89% for clinically significant cancer, which is what makes MRI usable as a triage test before biopsy.
• It lets many men skip the biopsy altogether. PROMIS estimated that using MRI to triage would allow about 27% of men to avoid a primary biopsy; in the PRECISION trial, 28% of men in the MRI arm had a scan that was not suspicious and were not biopsied at all.
• When a biopsy is needed, targeting finds more of the cancers that matter. In PRECISION, MRI-targeted biopsy diagnosed clinically significant cancer in 38% of men versus 26% with standard biopsy — using a median of only 4 cores instead of 12.
• It reduces overdiagnosis. PRECISION also found 13 percentage points fewer diagnoses of clinically insignificant cancer in the MRI-targeted group — fewer men labelled with a cancer that was never going to harm them.

Limitations of prostate MRI

• It is expensive compared with conventional ultrasound.
• It is not very specific. In PROMIS, specificity was only 41% and the positive predictive value 51% — meaning a suspicious-looking area is roughly a coin flip, and a scan that looks abnormal still has to be confirmed by biopsy.
• Some scanners require an endorectal coil to be placed in the rectum to improve image quality, which many men find uncomfortable.
• A negative scan is reassuring, not a guarantee. A small number of significant cancers are still missed, which is why men with a negative MRI need continued PSA follow-up rather than simple discharge.

Few diagnoses cause as much anxiety as suspected prostate cancer, and I hope this article helps you understand your options more clearly. If you have further questions, please discuss them with a urologist you trust.

영상 검사와 조직 검사에서 유의미한 암이 확인되면 수술이 종종 확실한 치료법이 됩니다. ...에 대해 알아보세요. 다빈치 전립선암 수술 그리고 회복이 현실적으로 무엇을 수반하는지.

If you have an elevated PSA and would like an MRI prostate evaluation before considering a biopsy, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 진료 예약.

MRI 전립선 자주 묻는 질문

MRI 전립선은 무엇을 위해 사용되나요?

전립선 MRI는 PSA 수치가 높아진 남성의 전립선 평가에 사용되는 비침습적 영상 도구입니다. 이는 비뇨의학과 의사들이 공격적인 전립선암을 나타낼 수 있는 의심스러운 부위를 식별하고 조직 검사가 필요한지 여부를 결정하는 데 도움을 주어 불필요한 침습적 시술을 줄여줍니다.

MRI 전립선 검사가 암을 발견하는 데 얼마나 정확한가요?

In the PROMIS study, multiparametric MRI detected 93% of clinically significant prostate cancers, compared with 48% for standard transrectal ultrasound-guided biopsy, with a negative predictive value of 89%. Its weakness is specificity, which was 41%, so a suspicious scan still needs biopsy confirmation. In the PRECISION trial, MRI-targeted biopsy diagnosed clinically significant cancer in 38% of men versus 26% with standard biopsy.

MRI 전립선 검사가 전립선 조직검사를 대체할 수 있나요?

No, MRI prostate cannot fully replace biopsy. If MRI shows suspicious findings, a biopsy is still required to confirm the diagnosis. However, MRI can spare a large number of men the procedure entirely: PROMIS estimated that around 27% of men could avoid a primary biopsy, and in PRECISION 28% of men in the MRI arm had a non-suspicious scan and were not biopsied.

MRI 전립선 촬영의 단점은 무엇입니까?

MRI prostate is more expensive than standard ultrasound, and it has limited specificity — 41% in the PROMIS study — so abnormal scans often turn out not to be significant cancer. In some cases an endorectal coil must be inserted into the rectum to improve image quality, which can be uncomfortable. It is also not a definitive diagnostic test, so a biopsy is still needed when findings are suspicious, and a small number of significant cancers can be missed.

전립선 MRI를 고려해야 하는 사람은 누구인가요?

전립선암이 의심되지만 이전 전립선 특이 항원(PSA) 수치가 높거나, 직장수지검사 결과가 비정상이거나, 이전 조직검사에서 음성으로 나왔지만 여전히 전립선암이 의심되는 남성이 MRI 전립선 검사의 가장 적합한 대상입니다. 비뇨의학과 의사가 개인의 상황을 평가하여 가장 적절한 영상 검사 전략을 추천할 것입니다.

참고 문헌

1. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815–822. PubMed
2. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis (PRECISION). N Engl J Med. 2018;378(19):1767–1777. PubMed

면책 조항: 본 내용은 방콕 병원 본사의 전문의인 Soarawee Weerasopone 박사가 작성하고 검토한 것입니다. 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 모든 의학적 치료를 시작하기 전에 항상 자격을 갖춘 의료 전문가와 상담하십시오.